Blogs
Speaking the Language of Inclusion: Localization’s Role in Giving a Voice to All in Clinical Trials
Localization is more than just translation—it’s about breaking down language barriers to ensure clinical trials are truly inclusive. By adapting trial materials for diverse linguistic…
Building Better eCOA: Quality, Engagement, and Scientific Integrity…and the People Who Bring This Together
Explore how YPrime’s patient-focused approach to eCOA enhances data quality, boosts patient engagement, and drives scientific excellence in clinical trials.
GLP-1 Clinical Trials: 5 Key Strategies and 5 Pitfalls to Avoid
Success in GLP-1 clinical trials requires a balanced approach that combines innovative strategies with careful attention to potential pitfalls. As sponsors navigate this growing pharmacological…
ICH E6(R3) Good Clinical Practice: Modernizing Clinical Trials and Aligning with YPrime’s Innovations
The International Council for Harmonisation of Technical Requirements for Human Use (ICH) issued the E6(R3) Good Clinical Practice Guideline on January 6, 2025. It updates…
Evaluating eCOA Options for Oncology Clinical Trials
The integration of connected devices in clinical trials enhances clinical research, elevating data collection, patient engagement, and overall study efficiency.
AI in Clinical Trials—The FDA’s New Draft Guidance
AI in Clinical Trials—The FDA’s New Draft Guidance A YPrime Blog By: Shawn Blackburn,Founder, YPrime On January 6, 2025, the FDA released a landmark draft…
Can Paper COA Deliver ALCOA?
With vulnerabilities like human error, ambiguous entries, and delayed documentation, paper COA falls short. Enter electronic clinical outcome assessments (eCOAs)—the only COA solution that not…
Connected Devices in Clinical Trials: Adoption Continues to Advance
The integration of connected devices in clinical trials enhances clinical research, elevating data collection, patient engagement, and overall study efficiency.
YPrime’s Commitment to the UN Global Compact
YPrime’s Commitment to the UN Global Compact—A Letter From Our CEO, Jim Corrigan A YPrime Blog By: Jim Corrigan,Chief Executive Officer, YPrime YPrime’s Commitment to…
We’ve got you covered with strategies and solutions to improve your clinical trial technology, reduce clinical research site burden, and transform your patient experience.
Let’s get started today!